APA (7th ed.) Citation

YY, L., M, L., A, C., A, D., LC, C., J, H., . . . M, K. (2025). FOLR1 as a therapeutic target in platinum-resistant ovarian carcinoma: Unique expression patterns across ovarian carcinoma histotypes and molecular subtypes of low-grade serous carcinoma. Journal of gynecologic oncology, 36(5), e74. https://doi.org/10.3802/jgo.2025.36.e74

Chicago Style (17th ed.) Citation

YY, Leung, et al. "FOLR1 as a Therapeutic Target in Platinum-resistant Ovarian Carcinoma: Unique Expression Patterns Across Ovarian Carcinoma Histotypes and Molecular Subtypes of Low-grade Serous Carcinoma." Journal of Gynecologic Oncology 36, no. 5 (2025): e74. https://doi.org/10.3802/jgo.2025.36.e74.

MLA (9th ed.) Citation

YY, Leung, et al. "FOLR1 as a Therapeutic Target in Platinum-resistant Ovarian Carcinoma: Unique Expression Patterns Across Ovarian Carcinoma Histotypes and Molecular Subtypes of Low-grade Serous Carcinoma." Journal of Gynecologic Oncology, vol. 36, no. 5, 2025, p. e74, https://doi.org/10.3802/jgo.2025.36.e74.